Yao, et al demonstrated that dosing of direct oral anticoagulants in patients with pre-existing renal dysfunction is inappropriate (ie, overdosed) in as many as 43% of patients. Moreover, as many as 13% of patients were underdosed. Overdosing led to increased bleeding risk without incremental stroke benefit, and underdosing led to increased stroke risk without incremental reduction in bleeding risk. Commentary: These results are provocative in that they indicate, in a real life sample of patients, frequent inappropriate dosing of direct oral anticoagulants in patients. Another article published this month by Yang, et al in Heart indicates that patients with kidney disease also carry a reduced time in therapeutic range when managed with warfarin. These results together indicate the importance of close consideration for anticoagulation management when considering renal dysfunction in atrial fibrillation patients.
